Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling
about
miR-155 as a Biomarker in B-Cell MalignanciesClinical significance of microRNAs in chronic and acute human leukemiaProangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic ApplicationsFocus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane VesiclesProstate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersTumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and TherapymiR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKTExtracellular Vesicles in Hematological Malignancies: From Biology to Therapy.ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression.MicroRNA-29b mediates altered innate immune development in acute leukemia.Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation.Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction.Novel mechanisms of regulation of miRNAs in CLL.MicroRNAs in extracellular vesicles: potential cancer biomarkers.State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.The emerging roles of tumor-derived exosomes in hematological malignancies.Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies.Isolation of Exosomes from HTLV-Infected Cells.XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles.Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells.Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.Tumor-derived exosomes modulate PD-L1 expression in monocytes.Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.Use of nanoparticle concentration as a tool to understand the structural properties of colloids.Microvesicles in CLL: predictor of disease progression/relapse.Extracellular vesicles in the hematopoietic microenvironment.MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D.An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.
P2860
Q26746573-815EBD29-028E-4D02-8FA5-1F6646B18B7AQ26749533-FB52F819-505E-436B-BAA2-B0082A4BB701Q26765924-9E9AE41B-73C8-40A7-9467-86DAC3A22A40Q26767270-B89BE5B0-C460-42E2-B087-1C6F10F79EB0Q28075610-9244527B-33CD-48B8-9D0D-3CA12C6930DEQ28817133-8F265D66-0504-45C6-B080-4D1C15163C43Q35702495-C872223B-2F1D-4DF6-941E-B1C5D5B0CDF6Q36390609-170F683A-5EC8-4EE3-B073-604DA9EA68F9Q37350228-A8260536-70A7-4723-BC12-625CB2A496E6Q37452181-4175E550-6C5B-4C50-8A8C-0496060025CAQ37619947-B6EC26DF-795F-4866-BCE9-E1A052C2E9B8Q38294212-2D2ACC17-7FAE-4E23-9D2D-A2DCC30301FCQ38550810-9A460F8D-642E-4713-A292-1EF5CE7173FAQ38749775-E90A4474-995B-43AC-A6C2-E239093AA079Q38837378-C78E3F99-F24B-4AD3-815F-6CCD2F1D5E41Q38841577-E72F22BC-EC00-4A4F-9043-EB12622A9EDAQ38887851-CC89B448-30C5-4F83-B239-62E240E65BA3Q39085428-B33043C4-2E1C-42B0-939A-A500CA56B510Q39188856-76C6D962-CA02-4690-9175-219C659EBBE3Q39354309-4942A692-9050-42FE-B0A9-77DABE6DF932Q40267375-FAC2A142-29CB-403D-A437-C42B93145644Q41817053-CC42EC5D-D11F-405F-8CAD-AF41C20EE3EEQ42361976-66B76193-AA2C-4020-A7A2-674702A58112Q45083622-22AD834B-A396-472D-9D75-6E26A136B524Q46011813-798AF516-F1CC-4171-9F0E-3CCDE9974EE1Q46329110-FCB7E3FA-73D1-4BC1-AE45-425173E4D16FQ46689848-868F8514-4C86-4CA9-AA18-F74FB8A6406FQ48223570-F3A22F95-FB2E-490B-8666-22184127C260Q49190687-9E8C8D28-E116-4CBA-85A2-0934279870EEQ50035099-04376BE8-BD6F-4BBC-BD33-434F5C61DE00Q51760643-DE7D117A-0AA2-4B8D-8B6F-1C0F320469B8Q51772193-6FC3E4DA-F108-4130-96DD-4D5886BB95DEQ52677584-7F95AA97-3204-4088-B101-B3D21F28BA12Q55176210-D94928E0-6BF8-4460-960D-CC4F5BE43678
P2860
Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization of CLL exosom ...... by activation of BCR signaling
@ast
Characterization of CLL exosom ...... by activation of BCR signaling
@en
type
label
Characterization of CLL exosom ...... by activation of BCR signaling
@ast
Characterization of CLL exosom ...... by activation of BCR signaling
@en
prefLabel
Characterization of CLL exosom ...... by activation of BCR signaling
@ast
Characterization of CLL exosom ...... by activation of BCR signaling
@en
P2093
P2860
P1433
P1476
Characterization of CLL exosom ...... by activation of BCR signaling
@en
P2093
Amy J Johnson
Amy M Lehman
Hatice Gulcin Ozer
Kami Maddocks
Yuh-Ying Yeh
P2860
P304
P356
10.1182/BLOOD-2014-12-618470
P407
P50
P577
2015-04-01T00:00:00Z